Industry Insights Logo

An Emerging Threat to Your 340B Program: DSH Percentage Reductions

SPONSORED CONTENT

The 340B program has been bombarded with threats over the past five years. 340B professionals have had their hands full defending the safety net program from contract pharmacy restrictions, state-level reporting, proposed legislative changes, the IRA, rebate models, and

Read More »

RxParadigm

Q: Tell us some interesting details about your company’s history.

RxParadigm was built to stay ahead of the curve in healthcare’s most complex arenas. From our inception, we’ve focused

Read More »
Industry Insights Logo

FQHCs Face Unique Challenges—Strong Partnerships Can Make All the Difference

SPONSORED CONTENT

Federally Qualified Health Centers (FQHCs) play a critical role in delivering accessible and affordable healthcare to underserved communities. However, they are facing mounting challenges that threaten their ability to maintain operations and meet growing community needs. With limited infrastructure, evolving regulations, upcoming Medicaid cuts, drops in the insured

Read More »
Industry Insights Logo

Resolving Negative Accumulations in a Virtual Inventory: What Would You Do?

SPONSORED CONTENT

Consider the following scenario: A recent change in electronic health record billing at one of your outpatient clinics has led to accumulation errors in your 340B split-billing software, resulting in overpurchasing of 340B drugs. Although hypothetical, this scenario illustrates just one of many inventory-related situations

Read More »

Expert Tip from AuthorityRx

img
img

TIP: Pay close attention and continually prepare for the possibility of a full rebate model.


HRSA’s recent

Read More »
Industry Insights Logo

Rethinking 340B: Where Compliance Ends and Strategy Begins

SPONSORED CONTENT

Let’s be honest. 340B compliance is demanding. It takes time, coordination, and precision. After more than a decade working in 340B compliance and auditing, I’ve learned it always comes back to one thing: the data.

Where does the data come from? How accurate is it? How quickly

Read More »
Industry Insights Logo

Part 3 of a 4-Part Series: Is In-House Pharmacy Capture the Overlooked Strategy to Growing Your 340B Program?

SPONSORED CONTENT

The 340B program is facing a period of unprecedented change. With the Inflation Reduction Act (IRA) and Medicare’s Maximum Fair Price (MFP) provisions set to take effect in 2026, covered entities can expect significant shifts—most notably, reduced drug reimbursement and

Read More »

Expert Tip from VytlOne

img
img

TIP: Take these six steps to build a strong data analytics foundation.


Data analytics is transforming healthcare,

Read More »
Industry Insights Logo

Mission Multiplied: Unlocking the Full Potential of 340B to Fuel Community Health

SPONSORED CONTENT

When it comes to doing more with less, Community Health Centers (CHCs) and Federally Qualified Health Centers (FQHCs) are unmatched. These mission-driven organizations are lifelines in underserved communities, delivering critical care where it’s needed most. And for many, the 340B program has become

Read More »

340B INDUSTRY LEADER SPOTLIGHT

Clay Cooper, Director, Insights Execution & Innovation, VytlOne

Clay Cooper

Q: Where did you grow up?

I grew up in Henderson, TN. It’s a small town in southwest Tennessee. It’s a very rural area; very large farming community. I still live in the area, in the next small town over called Selmer.

Q: Where did you go to college?

I earned my B.S. in Education at

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live